Europe launches pilot to streamline approvals

11 February 2025

The European Commission has launched a pilot program to simplify the approval process for certain clinical studies conducted across multiple European Union (EU) countries. The initiative aims to streamline applications, allowing sponsors to submit a single request for coordinated assessment.

By centralizing interactions with national authorities, the program seeks to create a more predictable process for approvals. It is designed to reduce administrative burdens, improve communication between countries, and ensure greater consistency in decision-making.

Sponsors can engage with all participating EU states simultaneously, avoiding delays caused by differing national interpretations. The program also aims to standardize requests for additional information, making the process more efficient.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical